Update: 02.05.2024
Last week: 17 week 2024 (22.04.2024 - 28.04.2024)
Last full month: March 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 688 | -5.6% | 12.2% | 0.1 | 19 009 525 | -6.1% | 10.2% | 0 | -6.5% |
| MoM | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| YTD | 124 932 | 23.9% | 11.0% | 2.4 | 279 423 356 | 53.6% | 9.5% | 2.2 | -2.8% |
| MAT | 364 942 | 31.8% | 9.9% | 1.7 | 754 361 417 | 48.7% | 8.4% | 1.4 | 8.6% |
| BRAINMAX | |||||||||
| WoW | 1 212 | 0.7% | 100.0% | 0 | 4 438 751 | 3.4% | 100.0% | 0 | 0.7% |
| MoM | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| YTD | 17 669 | 54.5% | 100.0% | 0 | 63 653 441 | 64.6% | 100.0% | 0 | 54.5% |
| MAT | 52 881 | 144.5% | 100.0% | NA | 185 976 757 | 160.3% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 18 832 | -5.1% | 45.7% | -1.2 | 59 317 781 | -4.5% | 37.3% | -1.2 | -2.6% |
| MoM | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| YTD | 290 549 | 0.7% | 44.5% | 1.9 | 925 656 896 | 5.9% | 36.4% | -2.5 | -3.5% |
| MAT | 871 139 | 15.8% | 45.6% | 1.9 | 2 743 675 454 | 24.6% | 38.8% | 0.2 | 11.0% |
| MIGRENIUM | |||||||||
| WoW | 13 788 | -7.3% | 0.6% | 0 | 4 419 595 | -6.4% | 0.8% | 0 | -1.9% |
| MoM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| YTD | 213 574 | 2.6% | 0.6% | -0.1 | 62 526 208 | 66.8% | 0.7% | 0.1 | 18.3% |
| MAT | 646 965 | 8.0% | 0.5% | 0 | 147 696 318 | 35.9% | 0.5% | 0 | 16.5% |
| MODELAX-N | |||||||||
| WoW | 31 387 | -5.0% | 24.5% | -0.8 | 13 726 571 | -4.4% | 16.2% | -0.6 | -1.7% |
| MoM | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| YTD | 544 058 | 55.7% | 23.9% | 5.9 | 225 077 822 | 104.3% | 15.0% | 4.8 | 17.4% |
| MAT | 1 362 581 | 101.1% | 20.6% | 7.9 | 497 741 741 | 125.2% | 12.1% | 4.8 | 24.2% |
| REDUXIN | |||||||||
| WoW | 13 528 | -1.4% | 32.9% | 0.4 | 72 333 490 | 0.4% | 45.5% | 0.8 | -2.6% |
| MoM | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| YTD | 216 313 | -7.7% | 33.1% | -1.5 | 1 176 003 538 | 22.8% | 46.2% | 3.7 | -3.5% |
| MAT | 619 899 | 1.6% | 32.4% | -3 | 3 091 655 420 | 22.7% | 43.7% | -0.4 | 11.0% |
| REDUXIN FORTE | |||||||||
| WoW | 3 717 | 4.2% | 9.0% | 0.6 | 15 626 779 | 1.4% | 9.8% | 0.3 | -2.6% |
| MoM | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| YTD | 56 768 | 5.0% | 8.7% | 0.7 | 247 622 652 | 22.7% | 9.7% | 0.8 | -3.5% |
| MAT | 168 703 | 26.0% | 8.8% | 1.1 | 699 352 199 | 38.1% | 9.9% | 1 | 11.0% |
| SALVISAR | |||||||||
| WoW | 14 559 | -1.3% | 1.8% | 0 | 6 069 687 | -0.6% | 1.7% | 0 | -3.8% |
| MoM | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
| YTD | 176 643 | -4.4% | 1.4% | -0.1 | 68 363 346 | 14.8% | 1.2% | -0.1 | 5.5% |
| MAT | 490 175 | -18.0% | 1.2% | -0.4 | 172 546 517 | -15.1% | 1.0% | -0.4 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 124 932 | 23.9% | 11.0% | 2.4 | 279 423 356 | 53.6% | 9.5% | 2.2 | -2.8% |
| BRAINMAX | 17 669 | 54.5% | 100.0% | 0 | 63 653 441 | 64.6% | 100.0% | 0 | 54.5% |
| GOLDLINE PLUS | 290 549 | 0.7% | 44.5% | 1.9 | 925 656 896 | 5.9% | 36.4% | -2.5 | -3.5% |
| MIGRENIUM | 213 574 | 2.6% | 0.6% | -0.1 | 62 526 208 | 66.8% | 0.7% | 0.1 | 18.3% |
| MODELAX-N | 544 058 | 55.7% | 23.9% | 5.9 | 225 077 822 | 104.3% | 15.0% | 4.8 | 17.4% |
| REDUXIN CAPS | 216 313 | -7.7% | 33.1% | -1.5 | 1 176 003 538 | 22.8% | 46.2% | 3.7 | -3.5% |
| REDUXIN FORTE | 56 768 | 5.0% | 8.7% | 0.7 | 247 622 652 | 22.7% | 9.7% | 0.8 | -3.5% |
| SALVISAR | 176 643 | -4.4% | 1.4% | -0.1 | 68 363 346 | 14.8% | 1.2% | -0.1 | 5.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 364 942 | 31.8% | 9.9% | 1.7 | 754 361 417 | 48.7% | 8.4% | 1.4 | 8.6% |
| BRAINMAX | 52 881 | 144.5% | 100.0% | NA | 185 976 757 | 160.3% | 100.0% | NA | NA |
| GOLDLINE PLUS | 871 139 | 15.8% | 45.6% | 1.9 | 2 743 675 454 | 24.6% | 38.8% | 0.2 | 11.0% |
| MIGRENIUM | 646 965 | 8.0% | 0.5% | 0 | 147 696 318 | 35.9% | 0.5% | 0 | 16.5% |
| MODELAX-N | 1 362 581 | 101.1% | 20.6% | 7.9 | 497 741 741 | 125.2% | 12.1% | 4.8 | 24.2% |
| REDUXIN CAPS | 619 899 | 1.6% | 32.4% | -3 | 3 091 655 420 | 22.7% | 43.7% | -0.4 | 11.0% |
| REDUXIN FORTE | 168 703 | 26.0% | 8.8% | 1.1 | 699 352 199 | 38.1% | 9.9% | 1 | 11.0% |
| SALVISAR | 490 175 | -18.0% | 1.2% | -0.4 | 172 546 517 | -15.1% | 1.0% | -0.4 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 688 | -5.6% | 12.2% | 0.1 | 19 009 525 | -6.1% | 10.2% | 0 | -6.5% |
| BRAINMAX | 1 212 | 0.7% | 100.0% | 0 | 4 438 751 | 3.4% | 100.0% | 0 | 0.7% |
| GOLDLINE PLUS | 18 832 | -5.1% | 45.7% | -1.2 | 59 317 781 | -4.5% | 37.3% | -1.2 | -2.6% |
| MIGRENIUM | 13 788 | -7.3% | 0.6% | 0 | 4 419 595 | -6.4% | 0.8% | 0 | -1.9% |
| MODELAX-N | 31 387 | -5.0% | 24.5% | -0.8 | 13 726 571 | -4.4% | 16.2% | -0.6 | -1.7% |
| REDUXIN CAPS | 13 528 | -1.4% | 32.9% | 0.4 | 72 333 490 | 0.4% | 45.5% | 0.8 | -2.6% |
| REDUXIN FORTE | 3 717 | 4.2% | 9.0% | 0.6 | 15 626 779 | 1.4% | 9.8% | 0.3 | -2.6% |
| SALVISAR | 14 559 | -1.3% | 1.8% | 0 | 6 069 687 | -0.6% | 1.7% | 0 | -3.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| BRAINMAX | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| GOLDLINE PLUS | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| MIGRENIUM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| MODELAX-N | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| REDUXIN CAPS | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| REDUXIN FORTE | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| SALVISAR | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs